-
- Dong Liying
- Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
-
- Hu Shasha
- Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
-
- Gao Jianjun
- Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.
この論文をさがす
説明
<p>The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.</p>
収録刊行物
-
- Drug Discoveries & Therapeutics
-
Drug Discoveries & Therapeutics 14 (1), 58-60, 2020-02-29
特定非営利活動法人 バイオ＆ソーシャル・サイエンス推進国際研究交流会